CV Sciences Inc (OTCMKTS:CVSI) today announced its business collaboration with Harris Teeter. These two business giants target expanding CV Sciences Inc’s PlusCBD™ Oil brand that has been dominating the market for long.
CV Sciences and the products it sells
Market observers applaud CV Sciences over its expansion into the Food, Drug, and Mass (FDM) retailer channel. It works well in terms of broadening the reach and availability of the company’s product, according to them. The company also deals with other products, including PlusCBD™ Oil Roll-Ons and Extra Strength Balms. These two businesses have reached an agreement to support the distribution of the products.
CV Sciences counts on Harris Teeter’s locations to generate higher revenues. These locations are in Maryland, Florida, Virginia, North, and South Carolina. An official working with CV Sciences says they are impressed with the expansion since it increases their distribution locations by a significant margin. According to him, they are now talking about 5,400 retail locations throughout the U.S.
Chief Executive Officer of CV Sciences Joseph Dowling says they won’t stop in their efforts to grow the distribution and the availability of their products. He believes the collaboration with Harris Teeter will work in their favor. The company’s PlusCBD™ Oil brand will soon be availed in the networking technique FDM channel.
Dowling opined, “CV Sciences has made significant distribution gains this year as FDM retailers such as Harris Teeter enter the hemp CBD market with a focus on making high quality, safe, and efficacious products available to their shoppers.”
The demand for CV Sciences’ products is increasing with time. This company is reacting to that by channeling more resources towards increasing its distribution points. It also seeks to expand its two distinct business segments. These are the drug development division and the consumer product division. The former focuses on manufacturing, marketing, and the sale of plant-based products. On the other hand, the latter develops and commercializes CBD-based novel therapeutics by utilizing CBD.
Leading researcher SPINS has ranked the Company’s PlusCBD™ Oil, terming it one of the best selling brands.
CV Sciences is also known to have in place a top-end facility that adheres to all guidelines and best practices. The company also hopes to do more towards enhancing the activities here.
Generex Biotechnology Corporation (OTCMKTS:GNBT) Submits Pre-IND For Ii-Key-SARS-CoV-2 Vaccine To The FDA
Post Views: 118 Generex Biotechnology Corporation (OTCMKTS:GNBT) submitted a Pre-IND update to the FDA outlining its proposed Phase I/II clinical...
cbdMD Inc. (NYSEAMERICAN:YCBD) Protecting Its CBD Technologies Through Patents and expands Partnership With Bellator MMA
Post Views: 279 cbdMD Inc. (NYSEAMERICAN:YCBD) announced an extension of the exclusive Official CBD marketing partnership with ViacomCBS’s wholly-owned subsidiary...
CLS Holdings USA Inc (OTCMKTS:CLSH) Increases Revenues In June 2020 By 5.35%
Post Views: 179 CLS Holdings USA Inc (OTCMKTS:CLSH) posted a growth of 5.35% YoY to $1.102 million in June 2020....
Canopy Rivers Inc.’s (OTCMKTS:CNPOF) Portfolio Companies Expanding Their Reach In Canada And The US
Post Views: 234 Canopy Rivers Inc.’s (OTCMKTS:CNPOF) three portfolio companies recently announced plans to expand their product offering for recreational...
AgraFlora Organics International Inc. (OTCMKTS:AGFAF) Processes Around 1,000KG Of CBD Crude Oil From 10,000Kg Of Hemp
Post Views: 299 AgraFlora Organics International Inc. (OTCMKTS:AGFAF) Toronto-based Sustainable Growth Strategic Capital Corp subsidiary in partnership with MicroC45 produced...
Marimed Inc (OTCMKTS:MRMD) Retires $7.3 Million Short-term Debt: Robust Sales Of Adult-Use Programs Improves Cash Flow
Post Views: 166 Marimed Inc (OTCMKTS:MRMD) restructured its debt to provide financial flexibility at reduced interest rates. Marimed replaced the...